ReviewDrug design, development and therapy2012

Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.

Claudio Gasperini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.